锘� Driving Compliance in Life Sciences Using Enterprise Asset Management Software

小蝌蚪视频

Call
Ask an Expert
Tel: +1-281-673-2800
Find an Office
Email
Email Us
Insight

Driving Compliance in Life Sciences Using Enterprise Asset Management Software

GENESISSOLUTIONS, AN ABS GROUP COMPANY

Validating Infor EAM to Drive Compliance in Life Sciences

Selecting, configuring and implementing computer systems within the industry can pose significant challenges for an organization in today's world of technology.

With ever-changing hardware and software advances, as well as improved abilities to integrate with other applications, devices and individual assets, organizations have more opportunities than ever to capture data, perform advanced analytics and trigger corrective, preventive or proactive events based on the actions of these interactions. However, these capabilities introduce complexity from a computer systems validation perspective.

Organizations are required to verify and validate that applications which have a direct or indirect impact on the products produced by an organization are working as designed. It is critical that the primary applications are compliant and support the regulatory requirements set forth by the U.S. Food and Drug Administration (FDA).

Our Asset Management service line helps organizations in other market sectors, such as Life Sciences, comply with FDA requirements through the implementation of enterprise-grade asset management software. 

Learn more by requesting our white paper, "Validating Infor EAM to Drive Compliance in Life Sciences."

From The Knowledge Center
Evaluating Critical Asset Safeguards for Pharmaceutical Manufacturers

Request Access to Paper


Thank You

Thank you for your inquiry. We will be in touch shortly to confirm your request for this resource. In the meantime, feel free to browse our full offering of Webinars, Insights and Project Profiles in the Knowledge Center.

Back to top